Tuesday, 04 May 2010 03:10

Strand Develops Genomic Reviewer Desktop Solution for the FDA

By Saurabh Narain

Strand today announced that it has entered into an agreement with the U.S. Food and Drug Administration (FDA) to deliver the Genomics Reviewer Desktop (GRD).

May 03, 2010, San Francisco, California - Strand Life Sciences (Strand), a pioneer in scientific intelligence, today announced that it has entered into an agreement with the U.S. Food and Drug Administration (FDA) to deliver the Genomics Reviewer Desktop (GRD), a solution to enable FDA reviewers to manage and analyze pharmacogenomic data submitted through its Voluntary Exploratory Data Submissions (VXDS) program. GRD will enable FDA to integrate analyses needed to reconstruct a sponsor's interpretation of exploratory biomarker data by using multiple genomics tools and methods. This effort contributes to the development of recommendations for the submission of genomic data.

GRD will be integrated with FDA's ArrayTrackâ„¢ and with other third party analysis software tools.  GRD is built on AVADIS®, Strand's award-winning workflow-driven data analysis and visualization platform that powers industry leading software products such as GeneSpring® and Sarchitectâ„¢.  As part of this agreement, FDA has also licensed Strand's AVADIS® software.

'There are a number of analysis tools, methods, and databases available to the FDA, along with our own ArrayTrackâ„¢, to analyze data submissions submitted as part of the VXDS program,' said Federico Goodsaid, Ph.D., Associate Director for Operations in Genomics, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S FDA. 'GRD will help FDA reviewers to develop integrated data interpretation that is based on using multiple analysis tools and databases, as well as capture the underlying analysis process. A solution such as GRD will be advantageous to both the FDA and the industry to manage pharmacogenomic data submissions.'

"We are very excited about this relationship with the FDA,' said Dr. Vijay Chandru, Chairman and CEO of Strand Life Sciences. "The GRD built on our award winning AVADIS® platform will help the FDA realize the benefits of integrating and standardizing analysis processes and systems in supporting the integration of genomics in drug development and regulatory decision-making".


BACK TO HOME PAGE

NEW OFFER - ITWIRE LAUNCHES PROMOTIONAL NEWS & CONTENT

Recently iTWire remodelled and relaunched how we approach "Sponsored Content" and this is now referred to as "Promotional News and Content”.

This repositioning of our promotional stories has come about due to customer focus groups and their feedback from PR firms, bloggers and advertising firms.

Your Promotional story will be prominently displayed on the Home Page.

We will also provide you with a second post that will be displayed on every page on the right hand side for at least 6 weeks and also it will appear for 4 weeks in the newsletter every day that goes to 75,000 readers twice daily.

POST YOUR NEWS ON ITWIRE NOW!

INVITE DENODO EXECUTIVE VIRTUAL ROUNDTABLE 9/7/20 1:30 PM AEST

CLOUD ADOPTION AND CHALLENGES

Denodo, the leader in data virtualisation, has announced a debate-style three-part Experts Roundtable Series, with the first event to be hosted in the APAC region.

The round table will feature high-level executives and thought leaders from some of the region’s most influential organisations.

They will debate the latest trends in cloud adoption and technologies altering the data management industry.

The debate will centre on the recently-published Denodo 2020 Global Cloud Survey.

To discover more and register for the event, please click the button below.

REGISTER HERE!

BACK TO HOME PAGE
BACK TO HOME PAGE

Webinars & Events

VENDOR NEWS

REVIEWS

Comments